Reply: Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD
JACC CardioOncol
.
2024 Jun 25;6(4):627.
doi: 10.1016/j.jaccao.2024.05.011.
eCollection 2024 Aug.
Authors
Christopher Yu
,
Paaladinesh Thavendiranathan
PMID:
39239347
PMCID:
PMC11372302
DOI:
10.1016/j.jaccao.2024.05.011
No abstract available